Brief: Lupin Receives U.S. FDA Approval For Phytonadione Injectable Emulsion
08/10/2026 16:30
BRIEF-Lupin Receives U.S. FDA Approval For Phytonadione Injectable Emulsion Oct 8 (Reuters) - Lupin Limited LUPN.NS:
LUPIN - RECEIVES FDA APPROVAL FOR PHYTONADIONE INJECTABLE EMULSION USP, 1 MG/0.5 ML
Source text: ID:nBSE3W5b7V
Further company coverage: LUPN.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Lupin
See all newsIndia's Lupin gains after US FDA nod for Phytonadione Injectable Emulsion
Brief: Lupin Receives U.S. FDA Approval For Phytonadione Injectable Emulsion
Brief: Lupin Announces Completion Of Buyback Of Shares By Multicare Pharmaceuticals Philippines
Brief: Lupin Receives Tentative U.S. FDA Approval For Apixaban Oral Suspension 1.25Mg/Ml Via 505(B)(2)
Lupin may pursue deals worth up to $2 billion, Nomura says